Eiry Roberts

Eiry Roberts

Chief Tech/Sci/R&D Officer at NEUROCRINE BIOSCIENCES, INC.

Net worth: 8 M $ as of 2026-10-30

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Presently, Eiry W. Roberts is Chief Medical Officer of Neurocrine Biosciences, Inc. In her past career she held the position of Vice President-Clinical Pharmacology & MD at Eli Lilly & Co. She received a doctorate from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-11-03 51,331 ( 0.05% ) 7 M $ 2026-10-30
2026-05-21 45,871 ( 0.01% ) 376 142 $ 2026-10-30

Eiry Roberts active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 2026-09-27
BAUSCH HEALTH COMPANIES INC. Director/Board Member 2026-05-18
Corporate Officer/Principal -

Former positions of Eiry Roberts

CompaniesPositionEnd
AMICUS THERAPEUTICS, INC. Director/Board Member 2026-04-26
NEUROCRINE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 2025-06-01
ELI LILLY AND COMPANY Corporate Officer/Principal 2017-11-30
Corporate Officer/Principal -
Director/Board Member -
See the detail of Eiry Roberts's experience

Education of Eiry Roberts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services